The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary
Abstract
The Maternal and Child Health Bureau commissioned the American College of Medical Genetics to outline a process of standardization of outcomes and guidelines for state newborn screening programs and to define responsibilities for collecting and evaluating outcome data, including a recommended uniform panel of conditions to include in state newborn screening programs. The expert panel identified 29 conditions for which screening should be mandated. An additional 25 conditions were identified because they are part of the differential diagnosis of a condition in the core panel, they are clinically significant and revealed with screening technology but lack an efficacious treatment, or they represent incidental findings for which there is potential clinical significance. The process of identification is described, and recommendations are provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Newborn screening is now universal in many countries, although it is limited to disorders combining high-throughput low-cost detection with effective early interventions (such as diet restrictions or enzyme replacement)142.”
From A brief history of human disease genetics (2020) · cites this paper as [142]
In the citing paper
“milder forms of other metabolic conditions may also be potentially missed by current newborn or biochemical screening tests, which have limits to their sensitivity (Watson et al., 2006).”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Watson et al., 2006
Citations
Cites
Serving the Family From Birth to the Medical Home
From the AAP Newborn Screening Task Force, E. G. V. (2000) · Pediatrics · doi:10.1542/peds.106.s2.389 · Cited by 244
Genetic Screening. Programs, Principles, and Research.
Erbe, R. W. (1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-86-4-514_3 · Cited by 118
Therrell, B. L., Panny, S. R., Davidson, A., Eckman, J. R., Hannon, W. H., Henson, M., Hillard, M. N., Kling, S., Levy, H. L., Meaney, F. J., et al. (1992) · Screening · doi:10.1016/0925-6164(92)90005-p · Cited by 66
Research works printed but not linked: 2
- US Congress, Office of Technology Assessment. Data and methods used in OTA's cost-effectiveness analysis of strategies for newborn screening. In: Healthy Children: Investing in the Future. Washington, DC: US Government Printing Office; 1988:236–241. Publication OTA-H-345. Available at: www.wws.princeton.edu/ota/ns20/alpha_f.html
- McCabe ERB. Principle of newborn screening for metabolic disease. Perinatol Neonatol. 1982;6:63–73
Cited by
A brief history of human disease genetics
Claussnitzer, M., Cho, J. H., Collins, R., Cox, N. J., Dermitzakis, E. T., Hurles, M. E., Kathiresan, S., Kenny, E. E., Lindgren, C. M., MacArthur, D. G., et al. (2020) · Nature · doi:10.1038/s41586-019-1879-7 · Cited by 697
Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units
Saunders, C. J., Miller, N. A., Soden, S. E., Dinwiddie, D. L., Noll, A., Alnadi, N. A., Andraws, N., Patterson, M. L., Krivohlavek, L. A., Fellis, J., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004041 · Cited by 656
Using Whole-Exome Sequencing to Identify Inherited Causes of Autism
Yu, T. W., Chahrour, M. H., Coulter, M. E., Jiralerspong, S., Okamura-Ikeda, K., Ataman, B., Schmitz-Abe, K., Harmin, D. A., Adli, M., Malik, A. N., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.11.002 · Cited by 442
“All human studies were reviewed and approved by the institutional review board of the Boston Children’s Hospital, Beth Israel Deaconess Medical Center, and local institutions.”
BackgroundStrategies for Implementing Screening for Critical Congenital Heart Disease
Kemper, A. R., Mahle, W. T., Martin, G. R., Cooley, W. C., Kumar, P., Morrow, W. R., Kelm, K., Pearson, G. D., Glidewell, J., Grosse, S. D., et al. (2011) · Pediatrics · doi:10.1542/peds.2011-1317 · Cited by 424
Self-citationMcHugh, D. M. S., Cameron, C. A., Abdenur, J. E., Abdulrahman, M., Adair, O., Al Nuaimi, S. A., Åhlman, H., Allen, J. J., Antonozzi, I., Archer, S., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31820d5e67 · Cited by 348
Metadata
- Authors
- Watson, M. S., Mann, M. Y., Lloyd-Puryear, M. A., Rinaldo, P., Howell, R. R., & American College of Medical Genetics Newborn Screening Expert Group
- Affiliations
- Mayo Clinic (US)
- University of Miami (US)
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2006-05-01
- Volume
- 117
- Issue
- Supplement_3
- Pages
- S296-S307
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2116729076
- Cited by
- 494
- References
- 3
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 31 · 2023: 32 · 2022: 37 · 2021: 26 · 2020: 37 · 2019: 28 · 2018: 27 · 2017: 24 · 2016: 25 · 2015: 26 · 2014: 19 · 2013: 26 · 2012: 30
- FWCI
- 12.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Keywords
- newborn screening, differential diagnosis, incidental finding, screening guidelines
- MeSH terms
- Cost-Benefit Analysis, Humans, Infant, Newborn, United States, Program Evaluation, Neonatal Screening, Guidelines as Topic, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary. https://app.cochat.ai/papers/10.1542/peds.2005-2633i
- The paper
- Watson, M. S., Mann, M. Y., Lloyd-Puryear, M. A., Rinaldo, P., Howell, R. R., & American College of Medical Genetics Newborn Screening Expert Group. (2006). Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary. Pediatrics. https://doi.org/10.1542/peds.2005-2633i
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.